ArticleBMC oral health2025
Global, regional, and national temporal trends in prevalence for nasopharynx cancer across adolescents and young adults, 1990-2021: an age-period-cohort analysis based on the global burden of disease study 2021.
Article in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Inflammatory-Hematological Profiles in Nasopharyngeal Carcinoma and Suspicious Adenoid Hypertrophy: An Exploratory Single-Center Study.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNasopharynx cancer (NPC) is a highly aggressive malignancy that is relatively rare on a global scale but exhibits marked geographic clustering, with high incidence in regions such as Southeast Asia, North Africa, and the Middle East. However, comprehensive global epidemiological assessments remain limited. This study analyzed temporal trends in the prevalence of NPC among adolescents and young adults (AYAs) from 1990 to 2021 using an age-period-cohort (APC) model.
methodsThis study utilized data from the Global Burden of Disease 2021. The study population comprised individuals aged 15-39 years. Age-standardized prevalence rates (ASPR) were calculated, with net and local drift used to assess overall and age-specific trends. The APC model was employed to separate the independent effects of age, period, and birth cohort on changes in NPC prevalence.
resultsFrom 1990 to 2021, the number of NPC cases among AYAs globally increased by 89.16%, reaching 128278.84 cases in 2021, although the ASPR rose only slightly (+0.21%/year, 95% CI: -0.02 to 0.44). A marked increase in ASPR was observed in the high-middle SDI region (+1.70%/year, 95% CI: 1.30 to 2.11), contrasting with declining trends in high SDI and low SDI regions. The age effect demonstrated increasing NPC prevalence with age, peaking in the 35-39 age group. Period effects revealed a resurgence in NPC risk after globally 2010, particularly in rapidly industrializing high-middle SDI regions. Birth cohort effects improved in high SDI regions but did not show significant improvement in high-middle SDI regions.
conclusionNPC among AYAs shows divergent regional trends, with sharp increases observed in high-middle SDI regions, suggesting a need for further investigation into region-specific risk patterns and public health responses to address the growing burden, particularly in resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.